The Wegovy pill comes in tablet form—and is the first U.S. Food & Drug Administration (FDA)-approved GLP-1 to do so. Its ...

Wegovy is now available as a daily pill, but experts say strict dosing schedules and more intense side effects may not make it a better option than the injection.

There's now a prescription GLP-1 pill for weight loss on the market. Here are six key things to know about it.

Wegovy Weight-Loss Pills Are Now Available in the U.S.—Here’s What That Means The first GLP-1 pills for weight loss are ...

A practice session at the Bell Centre was on the menu this morning for the Canadiens' players, as they prepare to take on the Flyers at home tonight. It should be noted at the outset that there were ...

Novo Nordisk has launched Ozempic, its once-weekly semaglutide injection for adults with type 2 diabetes, in the Indian market. The GLP-1 therapy, already widely used globally, offers blood-sugar ...

Dose, a crime drama about triad queenpin and a female cop, will kickstart a five-title partnership between KC Global Media and Rein Entertainment. The “highly-stylized” eight-part series is centered ...

Eli Lilly collaborates with the Trump administration to improve access to GLP-1 receptor agonists for millions of Americans, including those on government programs. The agreement allows Medicare ...

Starting with the critical hack to remove a stuck ring, this video delivers a daily dose of genius! Discover effortless tricks and shortcuts to solve common problems and simplify life right now.

J.P. Crawford (right) has played a central figure in the Mariners' return to postseason contention. Duane Burleson / Getty Images DETROIT — One win. It’s the margin that kept the Seattle Mariners from ...

Novo Nordisk A/S rose the most in a month after its diabetes blockbuster Ozempic beat Eli Lilly & Co.’s older drug Trulicity in a real-world survey of certain US patients. Medicare patients who took ...

Biogen (NASDAQ:BIIB) and Eisai (OTCPK:ESAIY) announced the rolling submission of a marketing application to receive an FDA label expansion for a subcutaneous autoinjector that delivers their Alzheimer ...